Agno Pharma, a global contract development and manufacturing organization (CDMO) specializing in small-molecule active ...
PharmTech spoke with Dr. Asma Patel, VP Global Commercial and Scientific Consulting–Drug Product, to find out how the growth ...
Market valued at $72.4M in 2024, projected 7.30% CAGR growth driven by pharmaceutical API synthesis, food-grade ...
Proposal aims to build a database of bulk drug traders, improve traceability of imported raw materials, over 70% of which ...
The move would dismantle the existing system under which bulk drugs and finished formulations operate under a common licence ...
In the fast-paced world of drug development, time is often the most precious commodity. For biotech companies working on oral ...
TRS offers a robust solution for analyzing heterogeneous samples, providing comprehensive spectral data essential for ...
In the regulated pharmaceutical sector, maintaining awareness and connectivity is vital. Industry professionals attend ...
AI and machine learning are revolutionizing drug discovery, development, and lifecycle management, addressing industry ...
Incyte Corporation is rated Strong Buy with recent execution driving a 56% stock rally and robust revenue growth. Learn more ...
Shardul Nautiyal, Mumbai Thursday, January 8, 2026, 08:00 Hrs [IST] ...
EOM Pharmaceutical Holdings, Inc. (OTC: IMUC) ("EOM") an innovative biotechnology company focused on developing transformative treatments for chronic inflammatory conditions and debilitating retinal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback